Dr. Saliba is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
200 1st Street SW
Rochester, MN 55905- Is this information wrong?
Summary
- Dr. Antoine Saliba is an internist in Rochester, MN and is affiliated with Mayo Clinic Hospital - Rochester. He received his medical degree from American University of Beirut Faculty of Medicine and has been in practice 3 years. He also speaks multiple languages, including Arabic and French. He specializes in hematology/oncology.
Education & Training
- Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 2019 - 2022
- Indiana University School of MedicineChief Residency, Internal Medicine, 2018 - 2019
- Indiana University School of MedicineResidency, Internal Medicine, 2015 - 2018
- American University of Beirut Faculty of MedicineClass of 2013
Certifications & Licensure
- MN State Medical License 2019 - 2024
- IN State Medical License 2015 - 2019
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- A phase I study of pevonedistat, azacitidine, and venetoclax in patients with relapsed/refractory acute myeloid leukemia.Guru Subramanian Guru Murthy, Antoine N Saliba, Aniko Szabo, Alexandra Harrington, Sameem Abedin, Karen Carlson, Laura Michaelis, Lyndsey Runaas, Arielle Baim, Alex Hi...> ;Haematologica. 2024 Apr 4
- Cardiac events in newly diagnosed acute myeloid leukaemia during treatment with venetoclax + hypomethylating agents.Isla M Johnson, Omer Karrar, Masooma Rana, Moazah Iftikhar, Sunny Chen, Kristen McCullough, Antoine N Saliba, Aref Al-Kali, Hassan Alkhateeb, Kebede Begna, Mark Litzow...> ;British Journal of Haematology. 2024 Apr 1
- Cladribine plus cytarabine plus venetoclax in acute myeloid leukemia relapsed or refractory to venetoclax plus hypomethylating agent.Nickolas Steinauer, Kristen McCullough, Aref Al-Kali, Hassan B Alkhateeb, Kebede H Begna, Abhishek A Mangaonkar, Antoine N Saliba, Mehrdad Torghabeh, Mark R Litzow, Wi...> ;Haematologica. 2024 Mar 28
- Join now to see all
Professional Memberships
- Member
- Member
- Member
Other Languages
- Arabic, French
Hospital Affiliations
- Mayo Clinic Hospital - RochesterRochester, Minnesota
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: